Wang R, Shen G, Huang M, Tian R. The diagnostic role of 18F-choline, 18F-fluciclovine and 18F-PSMA PET/CT in the detection of prostate cancer with biochemical recurrence: a meta-analysis. Front Oncol. 2021;11: 684629.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zattoni F, Ravelli I, Rensi M, Capobianco D, Borsatti E, Baresic T, et al. 10-year clinical experience with 18F-choline PET/CT: an Italian multicenter retrospective assessment of 3343 patients. Clin Nucl Med. 2020;45:594–603.

Article  PubMed  Google Scholar 

Alongi P, Laudicella R, Lanzafame H, Farolfi A, Mapelli P, Picchio M, et al. PSMA and choline PET for the assessment of response to therapy and survival outcomes in prostate cancer patients: a systematic review from the literature. Cancers. 2022;14(7):1770.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Petranović Ovčariček P, Giovanella L, Carrió Gasset I, Hindié E, Huellner MW, Luster M, et al. The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging. 2021;48(9):2801–22.

Article  PubMed  PubMed Central  Google Scholar 

Liberini V, Morand GB, Rupp NJ, Orita E, Deandreis D, Broglie Däppen M, et al. Histopathological features of parathyroid adenoma and 18F-choline uptake in PET/MR of primary hyperparathyroidism. Clin Nucl Med. 2022;47:101–7.

Article  PubMed  Google Scholar 

Treglia G, Giovannini E, Di Franco D, Calcagni ML, Rufini V, Picchio M, et al. The role of positron emission tomography using carbon-11 and fluorine-18 choline in tumors other than prostate cancer: a systematic review. Ann Nucl Med. 2012;26(6):451–61.

Article  CAS  PubMed  Google Scholar 

Broos WAM, Knol RJJ, van der Zant FM, Schaper NC, Wondergem M. Incidental findings on 18F-fluorocholine PET/CT for parathyroid imaging. World J Nucl Med. 2022;21:192–9.

Article  PubMed  PubMed Central  Google Scholar 

Alongi P, Quartuccio N, Arnone A, Kokomani A, Allocca M, Nappi AG, et al. Brain PET/CT using prostate cancer radiopharmaceutical agents in the evaluation of gliomas. Clin Transl Imaging. 2020;8:433–48.

Article  Google Scholar 

Beheshti M, Haroon A, Bomanji JB, Langsteger W. Fluorocholine PET/computed tomography: physiologic uptake, benign findings, and pitfalls. PET Clin. 2014;9(3):299–306.

Article  PubMed  Google Scholar 

Ricci F, Buzzatti G, Rubagotti A, Boccardo F. Safety of antiandrogen therapy for treating prostate cancer. Expert Opin Drug Saf. 2014;13(11):1483–99.

Article  CAS  PubMed  Google Scholar 

Bautista-Vidal C, Barnoiu O, García-Galisteo E, Gómez-Lechuga P, Baena-González V. Treatment of gynecomastia in patients with prostate cancer and androgen deprivation. Actas Urol Esp. 2014;38(1):34–40.

Article  CAS  PubMed  Google Scholar 

Alesini D, Iacovelli R, Palazzo A, Altavilla A, Risi E, Urbano F, et al. Multimodality treatment of gynecomastia in patients receiving antiandrogen therapy for prostate cancer in the era of abiraterone acetate and new antiandrogen molecules. Oncol. 2013;84(2):92–9.

Article  CAS  Google Scholar 

Sindoni A, Perin T, Borsatti E. Re: 18 F-Fluorocholine PET/CT of incidental male breast cancer. Clin Nucl Med. 2018;43(1):75–6.

Article  PubMed  Google Scholar 

Kwee SA, Coel MN. Detection of synchronous primary breast and prostate cancer by F-18 fluorocholine PET/CT. Clin Nucl Med. 2010;35(2):128–9.

Article  PubMed  Google Scholar 

Vadrucci M, Gilardi L, Grana CM. Breast cancer incidentally detected by 18F-choline PET/CT in a patient with recurrent prostate carcinoma. Clin Nucl Med. 2016;41(11):892–3.

Article  PubMed  Google Scholar 

Hugentobler A, Gilbeau L, Talbot JN, Gauthé M. 18F-Fluorocholine PET/CT of incidental male breast cancer. Clin Nucl Med. 2017;42(1):e56–7.

Article  PubMed  Google Scholar 

Ahmad Saad FF, Zakaria MH, Appanna B. PET/CT analysis of 21 patients with breast cancer: physiological distribution of 18 F-choline and diagnostic pitfalls. J Int Med Res. 2018;46:3138–48.

Article  PubMed  PubMed Central  Google Scholar 

Balma M, Liberini V, Racca M, Laudicella R, Bauckneht M, Buschiazzo A, et al. Non-conventional and investigational PET radiotracers for breast cancer: a systematic review. Front Med. 2022;9:1029.

Article  Google Scholar 

Mizusawa H, Komatsu A, Mimura Y, Maejima T. Development of male breast cancer in a patient with prostate cancer during androgen deprivation therapy. IJU Case Rep. 2022;5:118–21.

Article  PubMed  PubMed Central  Google Scholar 

Desser TS. Understanding transient hepatic attenuation differences. Semin Ultrasound CT MR. 2009;30:408–17.

Article  PubMed  Google Scholar 

Kim HJ, Kim AY, Kim TK, Byun JH, Won HJ, Kim KW, et al. Transient hepatic attenuation differences in focal hepatic lesions: dynamic CT features. AJR Am J Roentgenol. 2005;184:83–90.

Article  PubMed  Google Scholar 

Colagrande S, Centi N, Galdiero R, Ragozzino A. Transient hepatic intensity differences: part I, those associated with focal lesions. AJR Am J Roentgenol. 2007;188:154–9.

Article  PubMed  Google Scholar 

Colagrande S, Centi N, Galdiero R, Ragozzino A. Transient hepatic intensity differences: part 2, those not associated with focal lesions. Am J Roentgenol. 2007;188:160–6.

Article  Google Scholar 

Gu J. Primary liver cancer: challenges and perspectives. Biochim Biophys Acta Rev Cancer. 2020;1873(1): 188314.

Google Scholar 

Calabria F, Chiaravalloti A, Cicciò C, Gangemi V, Gullà D, Rocca F, et al. PET/CT with 18F–choline: physiological whole bio-distribution in male and female subjects and diagnostic pitfalls on 1000 prostate cancer patients: 18F–choline PET/CT bio-distribution and pitfalls. A southern Italian experience. Nucl Med Biol. 2017;51:40–54.

Article  CAS  PubMed  Google Scholar 

Ghidaglia J, Golse N, Pascale A, Sebagh M, Besson FL. 18F-FDG /18F-choline dual-tracer PET behavior and tumor differentiation in hepatocellular carcinoma. A systematic review Front Med. 2022;9: 924824.

Google Scholar 

Sandhu S, Moore CM, Chiong E, Beltran H, Bristow RG, Williams SG. Prostate cancer. Lancet. 2021;398:1075–90.

Article  CAS  PubMed  Google Scholar 

Gandaglia G, Abdollah F, Schiffmann J, Trudeau V, Shariat SF, Kim SP, et al. Distribution of metastatic sites in patients with prostate cancer: a population-based analysis. Prostate. 2014;74:210–6.

Article  PubMed  Google Scholar 

Van Den Esschert JW, Van Gulik TM, Phoa SSKS. Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma. Dig Surg. 2010;27:46–55.

Article  PubMed  Google Scholar 

Bieze M, Bennink RJ, El-Massoudi Y, Phoa SSKS, Verheij J, Beuers U, et al. The use of 18F-fluoromethylcholine PET/CT in differentiating focal nodular hyperplasia from hepatocellular adenoma: a prospective study of diagnostic accuracy. Nucl Med Commun. 2013;34:146–54.

Article  CAS  PubMed  Google Scholar 

Van Den Esschert JW, Bieze M, Beuers UH, Van Gulik TM, Bennink RJ. Differentiation of hepatocellular adenoma and focal nodular hyperplasia using 18F-fluorocholine PET/CT. Eur J Nucl Med Mol Imaging. 2011;38:436–40.

Article  PubMed  Google Scholar